Related Experiment Videos
Low level of prostacyclin as a risk of ischaemic heart disease
Insights
Children with a family history of ischemic heart disease show increased total cholesterol and decreased high-density lipoprotein (HDL) and prostacyclin levels. Lower prostacyclin may indicate early atherosclerotic disease in children.
Area of Science:
- Pediatrics
- Cardiovascular Science
- Biochemistry
Background:
- Ischemic heart disease (IHD) risk factors can manifest in childhood.
- Lipid metabolism and prostacyclin play crucial roles in cardiovascular health.
Purpose of the Study:
- To investigate the relationship between lipid levels and prostacyclin in children with a family history of IHD.
- To identify potential early indicators of atherosclerotic disease in pediatric populations.
Main Methods:
- Studied children aged 3-14 years with a family history of IHD.
- Measured serum total cholesterol and HDL-fraction levels.
- Assessed plasma prostacyclin (6-keto-prostaglandin F1a) and thromboxane B2 levels.
Main Results:
- Children exhibited significantly increased total serum cholesterol.
- Levels of HDL-fraction and prostacyclin significantly decreased.
- Plasma thromboxane B2 levels remained unchanged.
Conclusions:
- Childhood lipid metabolism abnormalities coexist with reduced prostacyclin levels in at-risk children.
- Decreased prostacyclin may serve as a novel indicator for early atherosclerotic disease.
- Early detection and intervention strategies for IHD risk in children are warranted.
Abstract:
We have studied the relationship between levels of lipids and prostacyclin in 3- to 14-year-old children with a family history of ischaemic heart disease. The total levels of cholesterol in the serum of these children increased, while levels of the HDL-fraction and prostacyclin (measured as 6-keto-prostaglandin F1a) decreased significantly. Levels of thromboxane B2 in the plasma were unchanged. It is suggested that, in childhood, abnormalities of lipid metabolism co-exist with decreased levels of prostacyclin. The latter may be a new important indicator of early atherosclerotic disease.